Gulf Coast Health Partners
ACO FAQs Partners Locations Find a Physician Education & Events Contact Us
an Accountable Care Organization
Consent Forms, Quality Measurements, Patient Portal, Healthy Communities        

Quality Measurements - 2016

Download the quality measurements table in a printable format >>

Measure Number Measure Name 2016 Reporting Period
ACO Performance Rate ACO Mean Performance Rate
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 81.09 80.51
ACO-2 CAHPS: How Well Your Providers Communicate 93.02 93.01
ACO-3 CAHPS: Patients’ Rating of Provider 92.85 92.25
ACO-4 CAHPS: Access to Specialists 81.19 83.49
ACO-5 CAHPS: Health Promotion and Education 58.06 60.32
ACO-6 CAHPS: Shared Decision Making 78.38 75.40
ACO-7 CAHPS: Health Status/Functional Status 71.71 72.30
ACO-34 CAHPS: Stewardship of Patient Resources 28.71 26.97
ACO-8 Risk Standardized, All Condition Readmission 13.94 14.7
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) 18.47 18.17
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 40.45 53.2
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 60.23 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 50.27 59.81
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 9.51 9.27
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 11.48 14.53
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements 96.52 82.72
ACO-39 Documentation of Current Medications in the Medical Record* 78.97 87.54
ACO-13 Falls: Screening for Future Fall Risk 86.24 64.04
ACO-14 Preventive Care and Screening: Influenza Immunization 67.82 68.32
ACO-15 Pneumonia Vaccination Status for Older Adults 72.44 69.21
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up 68.93 74.45
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 86.2 90.98
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 70.56 53.63
ACO-19 Colorectal Cancer Screening 69.72 61.52
ACO-20 Breast Cancer Screening 68.89 67.61
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 89.11 76.84
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 82.73 77.72
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 12.32 18.24
ACO-41 Diabetes: Eye Exam 35.21 44.94
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 73.31 70.52
ACO-30 Ischemic Vascular Disease(IVD): Use of Aspirin or Another Antithrombotic 82.94 85.05
ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LSVD) 94.49 88.67
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Blocker Receptor
Therapy - for patients with CAD and Diabetes or Left Ventricular Dysfunction Systolic (LVEF<40%)
39.25 79.67

CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.  

Note: In the Quality Performance Results file(s) above, search for “Northwest Florida Health Partners LLC” or "Gulf Coast Health Partners" to view the quality performance results. This ACO can also be found by using the ACO ID A39975 in the public use files on

2015 Quality Measurements

2012-2014 Quality Measurements

Public Reporting Information

Partners: Sacred Heart Health System and Providence Health System
Sacred Heart Health System Providence Health System Consent Forms Quality Measurements Patient Portal Healthy Communities Public Reporting Information Gulf Coast Health Partners